Kimberly Scearce‐Levie

10.5k citations

55 papers · 5.8k indexed · 1 hit paper · h-index 35

Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research 17
- Neurotransmitter Receptor Influence on Behavior 10
Physiology top 0.5%
- Alzheimer's disease research and treatments 20
Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms 7
Biological Psychiatry top 2%
Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases 5
Molecular Biology
- Receptor Mechanisms and Signaling 10
Computational Theory and Mathematics
- Computational Drug Discovery Methods 7
Social Psychology
- Neuroendocrine regulation and behavior 5

Co-authors: Lennart Mucke Jorge J. Palop Hertzel C. Gerstein Irene H. Cheng Tiffany Wu Gui-Qiu Yu Fengrong Yan Erik D. Roberson
Cited by: Cellular and Molecular Neuroscience Physiology Neurology
Partner nations: United States France Singapore

In The Last Decade

Kimberly Scearce‐Levie

55 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2007 Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Peers

Countries citing papers authored by Kimberly Scearce‐Levie

Since Specialization

Citations

This map shows the geographic impact of Kimberly Scearce‐Levie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Scearce‐Levie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Scearce‐Levie more than expected).

Fields of papers citing papers by Kimberly Scearce‐Levie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Scearce‐Levie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Scearce‐Levie. The network helps show where Kimberly Scearce‐Levie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kimberly Scearce‐Levie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kimberly Scearce‐Levie Line = papers co-authored together Kimberly Scearce‐Levie links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Leveraging preclinical models for the development of Alzheimer disease therapeutics Kimberly Scearce‐Levie,Pascal E. Sanchez,Joseph W. Lewcock	2020	76
2	Aging: therapeutics for a healthy future Robert A. Hodgson,Brian K. Kennedy,Eliezer Masliah,Kimberly Scearce‐Levie,Barbara Tate,Anjli Venkateswaran,Steven P. Braithwaite	2019	20
3	Mice deficient in NRROS show abnormal microglial development and neurological disorders Kit Hong Wong,Rajkumar Noubade,Paolo Manzanillo,Naruhisa Ota,Oded Foreman,Jason A. Hackney,Brad A. Friedman,Rajita Pappu,Kimberly Scearce‐Levie,Wenjun Ouyang	2017	48
4	Interfering with the Chronic Immune Response Rescues Chronic Degeneration After Traumatic Brain Injury Ali Ertürk,Susanne Mentz,Erik E. Stout,Maj Hedehus,Sara L. Domínguez,Lisa Neumaier,Franziska Krammer,Gemma Llovera,Karpagam Srinivasan,Matthew H. Bailey,Arthur Liesz,Kimberly Scearce‐Levie,Morgan Sheng	2016	68
5	Caspase-3 Deficiency Results in Disrupted Synaptic Homeostasis and Impaired Attention Control Shih‐Ching Lo,Yuan Yuan Wang,Martin Weber,Jessica L. Larson,Kimberly Scearce‐Levie,Morgan Sheng	2015	31
6	Chronic GluN2B Antagonism Disrupts Behavior in Wild-Type Mice Without Protecting Against Synapse Loss or Memory Impairment in Alzheimer's Disease Mouse Models Julien Hanson,William J. Meilandt,Alvin Gogineni,Paul Reynen,James Herrington,Robby M. Weimer,Kimberly Scearce‐Levie,Qiang Zhou	2014	19
7	GluN2B Antagonism Affects Interneurons and Leads to Immediate and Persistent Changes in Synaptic Plasticity, Oscillations, and Behavior Jesse E. Hanson,Martin Weber,William J. Meilandt,Tiffany Wu,Tom Luu,Lunbin Deng,Mehrdad Shamloo,Morgan Sheng,Kimberly Scearce‐Levie,Qiang Zhou	2013	44
8	Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing Xingrong Liu,Harvey Wong,Kimberly Scearce‐Levie,Ryan J. Watts,Melis Coraggio,Young G. Shin,Kun Peng,Kristin R. Wildsmith,Jasvinder K. Atwal,Jason Mango,Stephen Schauer,Kelly Regal,Kevin W. Hunt,Allen A. Thomas,Michael Siu,Joseph P. Lyssikatos,Gauri Deshmukh,Cornelis E. C. A. Hop	2013	17
9	SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition Jesse E. Hanson,Hank La,Emile G. Plise,Yung‐Hsiang Chen,Xiao Ding,Taleen Hanania,Emily Sabath,Vadim Alexandrov,Dani Brunner,Emer Leahy,Pascal Steiner,Lichuan Liu,Kimberly Scearce‐Levie,Qiang Zhou	2013	93
10	Monitoring Spatial Learning and Memory in Alzheimer’s Disease Mouse Models Using the Morris Water Maze Kimberly Scearce‐Levie	2010	17
11	Reduction in Mitochondrial Superoxide Dismutase Modulates Alzheimer's Disease-Like Pathology and Accelerates the Onset of Behavioral Changes in Human Amyloid Precursor Protein Transgenic Mice Luke Esposito,Jacob Raber,Lisa Kekonius,Fengrong Yan,Giu-Qiu Yu,Nga Bien‐Ly,Jukka Puoliväli,Kimberly Scearce‐Levie,Eliezer Masliah,Lennart Mucke	2006	215
12	Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease Jeannie Chin,Jorge J. Palop,Jukka Puoliväli,Catherine Massaro,Nga Bien‐Ly,Hertzel C. Gerstein,Kimberly Scearce‐Levie,Eliezer Masliah,Lennart Mucke	2005	265
13	Enkephalin contributes to the locomotor stimulating effects of 3,4‐methylenedioxy‐N‐methylamphetamine Valérie Compan,Kimberly Scearce‐Levie,Cyril Crosson,A. Daszuta,René Hen	2003	18
14	Tools for dissecting signaling pathways in vivo: Receptors activated solely by synthetic ligands Kimberly Scearce‐Levie,Peter Coward,Charles H. Redfern,Bruce R. Conklin	2002	5
15	Absence of Cocaine-induced Place Conditioning in Serotonin 1B Receptor Knock-out Mice Catherine Belzung,Kimberly Scearce‐Levie,Serge Barreau,René Hen	2000	31
16	Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists Nathalie Castanon,Kimberly Scearce‐Levie,José J. Lucas,Beatriz Rocha,René Hen	2000	73
17	Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT 1B receptor Kimberly Scearce‐Levie,Sandya S. Viswanathan,René Hen	1999	75
18	5‐HT Receptor Knockout Mice: Pharmacological Tools or Models of Psychiatric Disorders Kimberly Scearce‐Levie,Jue Chen,Eliot L. Gardner,René Hen	1999	49
19	5‐HT_1B Receptor Modulation of Prepulse Inhibition: Recent Findings in Wild‐type and 5‐HT_1B Knockout Mice^a Stephanie C. Dulawa,René Hen,Kimberly Scearce‐Levie,Mark A. Geyer	1998	31
20	Serotonin 1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin 1B knockout mice Stephanie C. Dulawa,René Hen,Kimberly Scearce‐Levie,Mark A. Geyer	1997	105

About Kimberly Scearce‐Levie

Kimberly Scearce‐Levie is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Neurology, having authored 55 papers that have together received 5.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (20 papers), Neuroscience and Neuropharmacology Research (17 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Computational Drug Discovery Methods (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Neuroendocrine regulation and behavior (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.1k citations), Physiology (3.0k citations) and Neurology (896 citations). Kimberly Scearce‐Levie has collaborated with scholars based in United States, France and Singapore. Frequent co-authors include Lennart Mucke, Jorge J. Palop, Hertzel C. Gerstein, Irene H. Cheng, Tiffany Wu, Gui-Qiu Yu, Fengrong Yan, Erik D. Roberson, René Hen and Nga Bien‐Ly.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact